FTSE All-Share

FTSE All-Share handeln
5.526,27 PKT -75,33 PKT -1,34 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
26.10.12 AstraZeneca hold Société Générale Group S.A. (SG)
26.10.12 Anglo American sell Société Générale Group S.A. (SG)
26.10.12 Unilever halten Independent Research GmbH
26.10.12 Unilever sell Société Générale Group S.A. (SG)
26.10.12 Glencore neutral Sarasin Research
26.10.12 Unilever equal-weight Morgan Stanley
26.10.12 BP neutral Goldman Sachs Group Inc.
26.10.12 HSBC outperform Credit Suisse Group
25.10.12 Shell (ex Royal Dutch Shell) buy Nomura
25.10.12 Unilever neutral Sarasin Research
25.10.12 GSK underperform Exane-BNP Paribas SA
25.10.12 Vodafone Group underperform Exane-BNP Paribas SA
25.10.12 BP neutral Citigroup Corp.
25.10.12 BAT buy Nomura
25.10.12 Standard Chartered buy Nomura
25.10.12 Unilever hold ING
25.10.12 BAT equal-weight Morgan Stanley
25.10.12 BAT outperform Exane-BNP Paribas SA
25.10.12 Marks Spencer underperform Exane-BNP Paribas SA
25.10.12 BAT halten Independent Research GmbH
25.10.12 AstraZeneca neutral Citigroup Corp.
25.10.12 Anglo American neutral Citigroup Corp.
25.10.12 Standard Chartered buy Citigroup Corp.
25.10.12 BAT hold Société Générale Group S.A. (SG)
25.10.12 Barclays buy Citigroup Corp.
24.10.12 HSBC buy Citigroup Corp.
24.10.12 BP outperform Credit Suisse Group
24.10.12 Imperial Brands neutral Goldman Sachs Group Inc.
24.10.12 ITV buy Nomura
24.10.12 National Grid overweight Morgan Stanley
24.10.12 BAE Systems equal-weight Morgan Stanley
24.10.12 BP outperform RBC Capital Markets
24.10.12 Lloyds Banking Group overweight HSBC
24.10.12 Diageo halten Independent Research GmbH
23.10.12 BP neutral Exane-BNP Paribas SA
23.10.12 BP buy UBS AG
23.10.12 BP hold Société Générale Group S.A. (SG)
23.10.12 Barclays neutral HSBC
23.10.12 BP halten Independent Research GmbH
23.10.12 Barclays outperform Exane-BNP Paribas SA